Today's results make it absolutely crystal clear that Brilacidin-UP works, with minimal if any side effects. None of the other medications can make that claim of efficacy coupled with great safety.

Even the most chicken-hearted investor, or the most rabid traders'-gang basher, must realize that the market cap is absurdly low for a company that has even one successful clinical trial, much less clinical trials for 3 drugs with multiple applications.

I wouldn't care if the basher gangs took the share price down to .50 now. In fact, I would (in all seriousness) mortgage my house to buy as much as I could at that price.